BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38388424)

  • 1. Nacc1 Mutation in Mice Models Rare Neurodevelopmental Disorder with Underlying Synaptic Dysfunction.
    Deehan MA; Kothuis JM; Sapp E; Chase K; Ke Y; Seeley C; Iuliano M; Kim E; Kennington L; Miller R; Boudi A; Shing K; Li X; Pfister E; Anaclet C; Brodsky M; Kegel-Gleason K; Aronin N; DiFiglia M
    J Neurosci; 2024 Apr; 44(14):. PubMed ID: 38388424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay.
    Schoch K; Meng L; Szelinger S; Bearden DR; Stray-Pedersen A; Busk OL; Stong N; Liston E; Cohn RD; Scaglia F; Rosenfeld JA; Tarpinian J; Skraban CM; Deardorff MA; Friedman JN; Akdemir ZC; Walley N; Mikati MA; Kranz PG; Jasien J; McConkie-Rosell A; McDonald M; Wechsler SB; Freemark M; Kansagra S; Freedman S; Bali D; Millan F; Bale S; Nelson SF; Lee H; Dorrani N; ; ; Goldstein DB; Xiao R; Yang Y; Posey JE; Martinez-Agosto JA; Lupski JR; Wangler MF; Shashi V
    Am J Hum Genet; 2017 Feb; 100(2):343-351. PubMed ID: 28132692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperkinetic Movement Disorder Caused by the Recurrent c.892C>T NACC1 Variant.
    Komulainen-Ebrahim J; Kangas SM; López-Martín E; Feyma T; Scaglia F; Martínez-Delgado B; Kuismin O; Suo-Palosaari M; Carr L; Hinttala R; Kurian MA; Uusimaa J
    Mov Disord Clin Pract; 2024 Jun; 11(6):708-715. PubMed ID: 38698576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intellectual-disability-associated mutation of the transcriptional regulator
    Daniel JA; Elizarova S; Shaib AH; Chouaib AA; Magnussen HM; Wang J; Brose N; Rhee J; Tirard M
    Front Mol Neurosci; 2023; 16():1115880. PubMed ID: 37533751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Case of
    Lyu B; Dong Y; Kang J
    Front Pediatr; 2021; 9():754261. PubMed ID: 34869110
    [No Abstract]   [Full Text] [Related]  

  • 6. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
    Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
    Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA FOXP4‑AS1 predicts poor prognosis and accelerates the progression of mantle cell lymphoma through the miR‑423‑5p/NACC1 pathway.
    Tao HF; Shen JX; Hou ZW; Chen SY; Su YZ; Fang JL
    Oncol Rep; 2021 Feb; 45(2):469-480. PubMed ID: 33416160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma.
    Yang T; Shen P; Chen Q; Wu P; Yuan H; Ge W; Meng L; Huang X; Fu Y; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
    J Exp Clin Cancer Res; 2021 Aug; 40(1):261. PubMed ID: 34416910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis.
    Cheng Z; Jiang S; Tao R; Ge H; Qin J
    Bioengineered; 2022 Feb; 13(2):2114-2129. PubMed ID: 35034547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA hsa_circ_0001588 promotes the malignant progression of lung adenocarcinoma by modulating miR-524-3p/NACC1 signaling.
    Sun Z
    Life Sci; 2020 Oct; 259():118157. PubMed ID: 32735888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.
    Shan W; Li J; Bai Y; Lu X
    Tumour Biol; 2016 Apr; 37(4):5203-11. PubMed ID: 26553360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of NAC1 expression is associated with defective bony patterning in the murine vertebral axis.
    Yap KL; Sysa-Shah P; Bolon B; Wu RC; Gao M; Herlinger AL; Wang F; Faiola F; Huso D; Gabrielson K; Wang TL; Wang J; Shih IeM
    PLoS One; 2013; 8(7):e69099. PubMed ID: 23922682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0027089 regulates NACC1 by targeting miR-136-5p to aggravate the development of hepatitis B virus-related hepatocellular carcinoma.
    He W; Zhu X; Tang X; Xiang X; Yu J; Sun H
    Anticancer Drugs; 2022 Jan; 33(1):e336-e348. PubMed ID: 34419960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interneuron Transplantation Rescues Social Behavior Deficits without Restoring Wild-Type Physiology in a Mouse Model of Autism with Excessive Synaptic Inhibition.
    Southwell DG; Seifikar H; Malik R; Lavi K; Vogt D; Rubenstein JL; Sohal VS
    J Neurosci; 2020 Mar; 40(11):2215-2227. PubMed ID: 31988060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the co-transcription factor NACC1: Beyond its pro-tumor effects.
    Xie Q; Tong C; Xiong X
    Life Sci; 2024 Jan; 336():122314. PubMed ID: 38030057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene replacement ameliorates deficits in mouse and human models of cyclin-dependent kinase-like 5 disorder.
    Gao Y; Irvine EE; Eleftheriadou I; Naranjo CJ; Hearn-Yeates F; Bosch L; Glegola JA; Murdoch L; Czerniak A; Meloni I; Renieri A; Kinali M; Mazarakis ND
    Brain; 2020 Mar; 143(3):811-832. PubMed ID: 32125365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of CC2D1A in Glutamatergic Neurons Results in Autistic-Like Features in Mice.
    Yang CY; Hung YC; Cheng KH; Ling P; Hsu KS
    Neurotherapeutics; 2021 Jul; 18(3):2021-2039. PubMed ID: 34132974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma.
    Shih IeM; Nakayama K; Wu G; Nakayama N; Zhang J; Wang TL
    Mod Pathol; 2011 May; 24(5):638-45. PubMed ID: 21240255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Low Grade Nasopharyngeal sarcoma With FUS::NACC1 Fusion and Immunohistochemical Evidence of Epithelial Differentiation: Expanding the Clinicopathologic Spectrum of an Emerging Entity.
    Rooper LM; Gagan J; Bishop JA
    Head Neck Pathol; 2023 Mar; 17(1):253-258. PubMed ID: 36169794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Etiological Foxp2 Mutation Impairs Neuronal Gain in Layer VI Cortico-Thalamic Cells through Increased GABA
    Druart M; Groszer M; Le Magueresse C
    J Neurosci; 2020 Oct; 40(44):8543-8555. PubMed ID: 33020214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.